Iovance Biotherapeutics(DE:2LB)
€7.03-0.24 (-3.30%)
DE:2LB
Iovance Biotherapeutics earnings date
€7.03
At close:-0.24 (-3.30%)
Iovance Biotherapeutics (2LB) Q3 2023 Earnings Report
19 Followers
DE:2LB Q3 2023 EPS Results
- Actual EPS
- -EUR 0.41
- Consensus EPS
- -EUR 0.41
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.56
DE:2LB Q3 2023 Revenue Results
- Actual Revenue
- EUR 419.92K
- Expected Revenue
- EUR 4.03M
- Beat/Miss
- Missed by -EUR 3.61M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/07/2023
- Time
- After Close
- Conference Call
- Tuesday, November 7, 2023
DE:2LB Upcoming Earnings
Iovance Biotherapeutics's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
DE:2LB Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2LB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.04- | -0.16 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.08-0.04 | -0.22 | 80.00% (+0.18) | |
| Aug 06, 2026 | 2026 (Q2) | -0.12-0.10 | -0.3 | 66.67% (+0.20) | |
| May 07, 2026 | 2026 (Q1) | -0.14-0.17 | -0.32 | 47.22% (+0.15) | |
| Feb 24, 2026 | 2025 (Q4) | -0.16-0.16 | -0.23 | 30.77% (+0.07) | |
| Nov 06, 2025 | 2025 (Q3) | -0.23-0.22 | -0.25 | 10.71% (+0.03) | |
| Aug 07, 2025 | 2025 (Q2) | -0.25-0.30 | -0.3 | 2.94% (+0.01) | |
| May 08, 2025 | 2025 (Q1) | -0.22-0.32 | -0.38 | 14.29% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.24-0.23 | -0.4 | 42.22% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -0.27-0.25 | -0.41 | 39.13% (+0.16) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
